284 related articles for article (PubMed ID: 10449799)
21. Mice with an induced mutation in collagen 8A2 develop larger eyes and are resistant to retinal ganglion cell damage in an experimental glaucoma model.
Steinhart MR; Cone FE; Nguyen C; Nguyen TD; Pease ME; Puk O; Graw J; Oglesby EN; Quigley HA
Mol Vis; 2012; 18():1093-106. PubMed ID: 22701298
[TBL] [Abstract][Full Text] [Related]
22. Effects of a non-selective beta-blocker on adult rat anterograde axonal transport and retinal ganglion layer after increased intraocular pressure.
Díaz F; Villena A; Moreno M; Vidal L; Parrado C; García-Campos J; de Vargas IP
Histol Histopathol; 2005 Oct; 20(4):1077-84. PubMed ID: 16136490
[TBL] [Abstract][Full Text] [Related]
23. Glaucomatous optic neuropathy: when glia misbehave.
Neufeld AH; Liu B
Neuroscientist; 2003 Dec; 9(6):485-95. PubMed ID: 14678581
[TBL] [Abstract][Full Text] [Related]
24. Upregulation of the endothelin A (ET
McGrady NR; Minton AZ; Stankowska DL; He S; Jefferies HB; Krishnamoorthy RR
BMC Neurosci; 2017 Mar; 18(1):27. PubMed ID: 28249604
[TBL] [Abstract][Full Text] [Related]
25. Inducible nitric oxide synthase inhibitors abolished histological protection by late ischemic preconditioning in rat retina.
Sakamoto K; Yonoki Y; Kubota Y; Kuwagata M; Saito M; Nakahara T; Ishii K
Exp Eye Res; 2006 Mar; 82(3):512-8. PubMed ID: 16198335
[TBL] [Abstract][Full Text] [Related]
26. The Ginkgo biloba extract (EGb 761) provides a neuroprotective effect on retinal ganglion cells in a rat model of chronic glaucoma.
Hirooka K; Tokuda M; Miyamoto O; Itano T; Baba T; Shiraga F
Curr Eye Res; 2004 Mar; 28(3):153-7. PubMed ID: 14977516
[TBL] [Abstract][Full Text] [Related]
27. An experimental basis for implicating excitotoxicity in glaucomatous optic neuropathy.
Vorwerk CK; Gorla MS; Dreyer EB
Surv Ophthalmol; 1999 Jun; 43 Suppl 1():S142-50. PubMed ID: 10416757
[TBL] [Abstract][Full Text] [Related]
28. Expression of neuronal nitric oxide synthase in the retina of a rat model of chronic glaucoma.
Park SH; Kim JH; Kim YH; Park CK
Vision Res; 2007 Sep; 47(21):2732-40. PubMed ID: 17825345
[TBL] [Abstract][Full Text] [Related]
29. Lamotrigine monotherapy does not provide protection against the loss of optic nerve axons in a rat model of ocular hypertension.
Marina N; Sajic M; Bull ND; Hyatt AJ; Berry D; Smith KJ; Martin KR
Exp Eye Res; 2012 Nov; 104():1-6. PubMed ID: 22982756
[TBL] [Abstract][Full Text] [Related]
30. Endothelin B receptors contribute to retinal ganglion cell loss in a rat model of glaucoma.
Minton AZ; Phatak NR; Stankowska DL; He S; Ma HY; Mueller BH; Jiang M; Luedtke R; Yang S; Brownlee C; Krishnamoorthy RR
PLoS One; 2012; 7(8):e43199. PubMed ID: 22916224
[TBL] [Abstract][Full Text] [Related]
31. Protective effect of a JNK inhibitor against retinal ganglion cell loss induced by acute moderate ocular hypertension.
Sun H; Wang Y; Pang IH; Shen J; Tang X; Li Y; Liu C; Li B
Mol Vis; 2011 Apr; 17():864-75. PubMed ID: 21527996
[TBL] [Abstract][Full Text] [Related]
32. Regulation of nitric oxide production by δ-opioid receptors during glaucomatous injury.
Husain S; Abdul Y; Singh S; Ahmad A; Husain M
PLoS One; 2014; 9(10):e110397. PubMed ID: 25329670
[TBL] [Abstract][Full Text] [Related]
33. Nitric oxide synthase in the human glaucomatous optic nerve head.
Neufeld AH; Hernandez MR; Gonzalez M
Arch Ophthalmol; 1997 Apr; 115(4):497-503. PubMed ID: 9109759
[TBL] [Abstract][Full Text] [Related]
34. A mouse ocular explant model that enables the study of living optic nerve head events after acute and chronic intraocular pressure elevation: Focusing on retinal ganglion cell axons and mitochondria.
Kimball EC; Pease ME; Steinhart MR; Oglesby EN; Pitha I; Nguyen C; Quigley HA
Exp Eye Res; 2017 Jul; 160():106-115. PubMed ID: 28414059
[TBL] [Abstract][Full Text] [Related]
35. Neuroprotective effects of angiotensin II type 1 receptor blocker in a rat model of chronic glaucoma.
Yang H; Hirooka K; Fukuda K; Shiraga F
Invest Ophthalmol Vis Sci; 2009 Dec; 50(12):5800-4. PubMed ID: 19608537
[TBL] [Abstract][Full Text] [Related]
36. Does elevated intraocular pressure reduce retinal TRKB-mediated survival signaling in experimental glaucoma?
Guo Y; Johnson E; Cepurna W; Jia L; Dyck J; Morrison JC
Exp Eye Res; 2009 Dec; 89(6):921-33. PubMed ID: 19682984
[TBL] [Abstract][Full Text] [Related]
37. Experimental and clinical evidence of neuroprotection by nerve growth factor eye drops: Implications for glaucoma.
Lambiase A; Aloe L; Centofanti M; Parisi V; Báo SN; Mantelli F; Colafrancesco V; Manni GL; Bucci MG; Bonini S; Levi-Montalcini R
Proc Natl Acad Sci U S A; 2009 Aug; 106(32):13469-74. PubMed ID: 19805021
[TBL] [Abstract][Full Text] [Related]
38. Protective effects of triptolide on retinal ganglion cells in a rat model of chronic glaucoma.
Yang F; Wang D; Wu L; Li Y
Drug Des Devel Ther; 2015; 9():6095-107. PubMed ID: 26604697
[TBL] [Abstract][Full Text] [Related]
39. Characterization of retinal damage in the episcleral vein cauterization rat glaucoma model.
Danias J; Shen F; Kavalarakis M; Chen B; Goldblum D; Lee K; Zamora MF; Su Y; Brodie SE; Podos SM; Mittag T
Exp Eye Res; 2006 Feb; 82(2):219-28. PubMed ID: 16109406
[TBL] [Abstract][Full Text] [Related]
40. Confirmation of the rat model of chronic, moderately elevated intraocular pressure.
Sawada A; Neufeld AH
Exp Eye Res; 1999 Nov; 69(5):525-31. PubMed ID: 10548472
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
